Innoveren Scientific (Innoveren Scientific) GF Value : $0.55 (As of May. 25, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Innoveren Scientific GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-25), Innoveren Scientific's share price is $0.0055. Innoveren Scientific's GF Value is $0.55. Therefore, Innoveren Scientific's Price-to-GF-Value for today is 0.01.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Innoveren Scientific is Possible Value Trap, Think Twice.

Innoveren Scientific (OTCPK:IVRN) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Innoveren Scientific's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	0.0055	/	0.55
	=	0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innoveren Scientific GF Value Related Terms

Thank you for viewing the detailed overview of Innoveren Scientific's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Innoveren Scientific (Innoveren Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innoveren Scientific Inc (OTCPK:IVRN) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

2202 N West Shore Boulevard, Suite 200, Tampa, FL, USA, 33607

Website

https://www.hcyte.com

Innoveren Scientific Inc Formerly H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.

Executives

Fwhc Holdings, Llc	10 percent owner	1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Hoa Capital Llc	10 percent owner	1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Farrior J Rex Iii	10 percent owner	1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Fwhc Bridge Friends, Llc	10 percent owner	1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Raymond Monteleone	director	201 E KENNEDY BLVD, STE 700, TAMPA FL 33602
Jeremy Daniel	officer: Chief Financial Officer	201 E KENNEDY AVE, STE 700, TAMPA FL 33602
Robert Smith Greif	officer: President and C.E.O.	19 MAY STREET, NEEDHAM MA 02492
Cfrs Investments, Llc	10 percent owner	2903 W VILLA ROSA PARK, TAMPA FL 33611
Frederick J Lynch	10 percent owner	C/O MASONITE INTERNATIONAL CORPORATION, 201 NORTH FRANKLIN ST., SUITE 300, TAMPA FL 33602
Fwhc Bridge, Llc	10 percent owner	334 EAST LAKE ROAD, SUITE 176, PALM HARBOT FL 34685
Todd R Wagner	10 percent owner	3385 OLD KEYSTONE ROAD, TARPON SPRINGS FL 34688
Michael Yurkowsky	director	2380 OLD MILTON PARKWAY, ALPHARETTA GA 30009
William E Horne	director, officer: Chief Executive Officer	201 EAST KENNEDY BLVD, SUITE 700, TAMPA FL 33602
Jon Mogford	director	714 PLUM HOLLOW DRIVE, COLLEGE STATION TX 77845
John C Thomas	director	8601 SIX FORKS ROAD, SUITE 160, RALEIGH NC 27615